The Pioneering Role of the Vaccine Safety Datalink Project (VSD) to Advance Collaborative Research and Distributed Data Networks
暂无分享,去创建一个
[1] Steven J. Jacobsen,et al. The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety , 2011, Pediatrics.
[2] Barbara Goodson,et al. Prenatal and Infant Exposure to Thimerosal From Vaccines and Immunoglobulins and Risk of Autism , 2010, Pediatrics.
[3] W Katherine Yih,et al. Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance. , 2012, Health affairs.
[4] John F. Steiner,et al. Sustaining Research Networks: the Twenty-Year Experience of the HMO Research Network , 2014, EGEMS.
[5] R. Davis. Vaccine Safety Surveillance Systems: Critical Elements and Lessons Learned in the Development of the US Vaccine Safety Datalink’s Rapid Cycle Analysis Capabilities , 2013, Pharmaceutics.
[6] Robert T. Chen,et al. Active Surveillance of Vaccine Safety: A System to Detect Early Signs of Adverse Events , 2005, Epidemiology.
[7] M. Manos,et al. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up? , 2005, Journal of the National Cancer Institute.
[8] Richard Platt,et al. The U.S. Food and Drug Administration's Mini‐Sentinel program: status and direction , 2012, Pharmacoepidemiology and drug safety.
[9] John W. Glasser,et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. , 1997, Pediatrics.
[10] R. Platt,et al. Targeted versus universal decolonization to prevent ICU infection. , 2013, The New England journal of medicine.
[11] R. Davis,et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. , 2007, The New England journal of medicine.
[12] L. Etheredge,et al. Rapid learning: a breakthrough agenda. , 2014, Health affairs.
[13] W Katherine Yih,et al. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. , 2012, American journal of epidemiology.
[14] W Katherine Yih,et al. Intussusception risk after rotavirus vaccination in U.S. infants. , 2014, The New England journal of medicine.
[15] R. Platt,et al. Risk of Guillain–Barré syndrome after meningococcal conjugate vaccination , 2012, Pharmacoepidemiology and drug safety.
[16] Nicola P Klein,et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. , 2012, JAMA.
[17] E. Belongia,et al. Risk of intussusception after monovalent rotavirus vaccination. , 2014, The New England journal of medicine.
[18] Fang Zhang,et al. A distributed research network model for post‐marketing safety studies: the Meningococcal Vaccine Study , 2008, Pharmacoepidemiology and drug safety.
[19] Erin Holve,et al. Ensuring Support for Research and Quality Improvement (QI) Networks: Four Pillars of Sustainability—An Emerging Framework , 2013, EGEMS.
[20] W Katherine Yih,et al. Active Surveillance for Adverse Events: The Experience of the Vaccine Safety Datalink Project , 2011, Pediatrics.
[21] R. Platt,et al. Distributed Health Data Networks: A Practical and Preferred Approach to Multi-Institutional Evaluations of Comparative Effectiveness, Safety, and Quality of Care , 2010, Medical care.
[22] R. Platt,et al. Developing the Sentinel System--a national resource for evidence development. , 2011, The New England journal of medicine.
[23] T. Cheetham,et al. Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink. , 2013, Vaccine.
[24] Richard Platt,et al. Four health data networks illustrate the potential for a shared national multipurpose big-data network. , 2014, Health affairs.